Margaret Gamalo

Margaret Gamalo

Auto-generated profile, based on publicly available information

Margaret Gamalo

Pfizer Inc. Collegeville Pennsylvania USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2017 in Pharmaceutical Statistics
Verified
Journal Article
Closed access
PDF file
MGMargaret Gamalo‐Siebers
Margaret Gamalo‐Siebers
JSJasmina Savic
Jasmina Savic
CBCynthia Basu
Cynthia Basu
XZXin Zhao
Xin Zhao
MGMathangi Gopalakrishnan
Mathangi Gopalakrishnan
BCBradley P. Carlin
Bradley P. Carlin

27 June 2022 in Pharmaceutical Statistics
Verified
Journal Article
Closed access
GDGaohong Dong
Gaohong Dong
BHBo Huang
Bo Huang
JVJohan Verbeeck
Johan Verbeeck
YCYing Cui
Ying Cui
JSJames Song
James Song
JKJohn Edward Kolassa
John Edward Kolassa

31 July 2018 in Pharmaceutical Statistics
Verified
Journal Article
Closed access
PDF file
JLJunjing Lin
Junjing Lin
MGMargaret Gamalo‐Siebers
Margaret Gamalo‐Siebers
RTRam Tiwari
Ram Tiwari

9 December 2018 in Pharmaceutical Statistics
Verified
Journal Article
Closed access
PDF file
JLJunjing Lin
Junjing Lin
MGMargaret Gamalo‐Siebers
Margaret Gamalo‐Siebers
RTRam Tiwari
Ram Tiwari

1 September 2019 in Therapeutic Innovation & Regulatory Science
Verified
Journal Article
Closed access
PDF file
Kathleen JobKathleen Job
Kathleen Job
MGMargaret Gamalo
Margaret Gamalo
RWRobert M. Ward
Robert M. Ward

10 August 2022 in Journal of Biopharmaceutical Statistics
Verified
Journal Article
Closed access
JSJames Song
James Song
JVJohan Verbeeck
Johan Verbeeck
BHBo Huang
Bo Huang
DHDavid C. Hoaglin
David C. Hoaglin
MGMargaret Gamalo-Siebers
Margaret Gamalo-Siebers
GDGaohong Dong
Gaohong Dong
Generalized pairwise comparisons and win statistics (i.e., win ratio, win odds and net benefit) are advantageous in analyzing and interpreting a composite of multiple outcomes in clinical trials. An important limitation of these statistics is their inability to adjust for covariates other than by stratified analysis. Because the win ratio does not account for ties, the win odds, a modification that includes ties, has attracted attention. We review and combine information on the win odds to articulate the statistical inferences for the win odds. We also show alternative variance estimators based on the exact permutation and bootstrap as well as statistical inference via the probabilistic index. Finally, we extend multiple-covariate regression probabilistic index models to the win odds with a univariate outcome. As an illustration we apply the regression models to the data in the CHARM trial.